Penile Neoplasms

5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Neoplasms

Treatments and conditions

Penile Neoplasms
Treatment and conditionWhere it standsTrials
9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Hansenula Polymorpha) for penile neoplasmsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cemiplimab for penile neoplasmsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Chemotherapy TIP for penile neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Partial or total penectomy with inguinal and/or pelvic lymph node dissection + PEMBROLIZUMAB + PYRUVATE CARBOXYLASE, MITOCHONDRIAL for penile neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PUCOTENLIMAB + Becotatug Vedotin for penile neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.